121 related articles for article (PubMed ID: 32477463)
21. Review: Oncogenic Insertional Mutagenesis as a Consequence of Retroviral Gene Therapy for X-Linked Severe Combined Immunodeficiency Disease.
Ahmed B; Zafar M; Qadir MI
Crit Rev Eukaryot Gene Expr; 2019; 29(6):511-520. PubMed ID: 32422006
[TBL] [Abstract][Full Text] [Related]
22. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
[TBL] [Abstract][Full Text] [Related]
23. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
24. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
25. SCL, GATA-2 and Lmo2 expression in neurogenesis.
Herberth B; Minkó K; Csillag A; Jaffredo T; Madarász E
Int J Dev Neurosci; 2005 Aug; 23(5):449-63. PubMed ID: 16011889
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of LMO2 causes aberrant human T-Cell development in vivo by three potentially distinct cellular mechanisms.
Wiekmeijer AS; Pike-Overzet K; Brugman MH; van Eggermond MCJA; Cordes M; de Haas EFE; Li Y; Oole E; van IJcken WFJ; Egeler RM; Meijerink JP; Staal FJT
Exp Hematol; 2016 Sep; 44(9):838-849.e9. PubMed ID: 27302866
[TBL] [Abstract][Full Text] [Related]
27. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
[TBL] [Abstract][Full Text] [Related]
28. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.
Grütz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH
EMBO J; 1998 Aug; 17(16):4594-605. PubMed ID: 9707419
[TBL] [Abstract][Full Text] [Related]
29. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
[TBL] [Abstract][Full Text] [Related]
31. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
[TBL] [Abstract][Full Text] [Related]
32. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.
García-Ramírez I; Bhatia S; Rodríguez-Hernández G; González-Herrero I; Walter C; González de Tena-Dávila S; Parvin S; Haas O; Woessmann W; Stanulla M; Schrappe M; Dugas M; Natkunam Y; Orfao A; Domínguez V; Pintado B; Blanco O; Alonso-López D; De Las Rivas J; Martín-Lorenzo A; Jiménez R; García Criado FJ; García Cenador MB; Lossos IS; Vicente-Dueñas C; Borkhardt A; Hauer J; Sánchez-García I
EMBO J; 2018 Jul; 37(14):. PubMed ID: 29880602
[TBL] [Abstract][Full Text] [Related]
33. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
34. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
Stanulovic VS; Cauchy P; Assi SA; Hoogenkamp M
Nucleic Acids Res; 2017 Sep; 45(17):9874-9888. PubMed ID: 28973433
[TBL] [Abstract][Full Text] [Related]
35. A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2.
Wang Q; Zhang M; Wang X; Yuan W; Chen D; Royer-Pokora B; Zhu T
Leukemia; 2007 May; 21(5):1015-25. PubMed ID: 17361224
[TBL] [Abstract][Full Text] [Related]
36. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
[TBL] [Abstract][Full Text] [Related]
37. Zebrafish scl functions independently in hematopoietic and endothelial development.
Dooley KA; Davidson AJ; Zon LI
Dev Biol; 2005 Jan; 277(2):522-36. PubMed ID: 15617691
[TBL] [Abstract][Full Text] [Related]
38. The PA207 peptide inhibitor of LIM-only protein 2 (Lmo2) targets Zinc Finger domains in a non-specific manner.
Wilkinson-White L; Matthews JM
Protein Pept Lett; 2014; 21(2):132-9. PubMed ID: 24188027
[TBL] [Abstract][Full Text] [Related]
39. Leukaemia -- a developmental perspective.
Izraeli S
Br J Haematol; 2004 Jul; 126(1):3-10. PubMed ID: 15198727
[TBL] [Abstract][Full Text] [Related]
40. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.
Tang T; Prasad KS; Koury MJ; Brandt SJ
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):615-20. PubMed ID: 10527940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
